Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to <em>Staphylococcus</em> treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France

<p class="p p-first" id="__p2"><strong>Introduction</strong>: In patients undergoing a « debridement, antibiotics, and implant retention » (DAIR) procedure for acute staphylococcal prosthetic joint infection (PJI), post-operative treatment with rifampin has been associated with a higher probability...

Cijeli opis

Bibliografski detalji

Glavni autori:	A. Becker, L. Kreitmann, C. Triffaut-Fillit, F. Valour, E. Mabrut, E. Forestier, O. Lesens, C. Cazorla, S. Descamps, B. Boyer, C. Chidiac, S. Lustig, E. Montbarbon, C. Batailler, T. Ferry
Format:	Artigo
Jezik:	Inglês
Izdano:	Copernicus Publications 2020-02-01
Serija:	Journal of Bone and Joint Infection
Online pristup:	https://jbji.copernicus.org/articles/5/28/2020/jbji-5-28-2020.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!